16
WFSBP 2017
Preliminary Scientific Programme /
WFSBP Task Force Symposia and Workshops
TFS-08-004
Sex differences in early predictors of adult personality
and intelligence
Trine Flensborg-Madsen, Denmark
T50: VIOLENCE: BASIC/CLINICAL
TFS-09
17:00–18:30
Providing acute inpatient care for children,
adolescents and young adults from a men's mental
health perspective: Focus on violence reduction
Chair:
Pilar Trelles, USA
Co-Chair: Lesha Shah, USA
TFS-09-001
Brain development: A focus on normal male develop-
ment and psychopathology
Pilar Trelles, USA
TFS-09-002
Asking for the IM: What to do when the disruptive male
child appears to seek punishment
Timothy Rice, USA
TFS-09-003
Agression in adolescence
Lesha Shah, USA
TFS-09-004
Violent and suicidal behavior among young male veter-
ans on an inpatient psychiatric unit
Leo Sher, USA
WFSBP Task Force Workshops
aa
Monday, 19 June 2017
T32: PHARMACOGENETICS
TFW-01
15:00–16:30
Workshop of the WFSBP Task Force on genetics: Focus
on pharmacogenomics
Chair:
Dan Rujescu, Germany
Co-Chair: Jim Kennedy, Canada
TFW-01-001
Pharmacogenetics in schizophrenia
Rainald Mössner, Germany
TFW-01-002
Largest genome wide association study on agranulocyto-
sis under Clozapine
Dan Rujescu, Germany
TFW-01-003
Whole exom sequencing reveals risk factors in treat-
ment resistant depression
Alessandro Serretti, Italy
TFW-01-004
Pharmacogenetic discoveries and applications in psychi-
atric populations
Jim Kennedy, Canada
aa
Tuesday, 20 June 2017
T13: EMERGENCY PSYCHIATRY
TFW-02
15:00–16:30
WFSBP consensus on the management of agitation in
psychiatry
Chair:
Siegfried Kasper, Austria
Co-Chair: Eduard Vieta, Spain
TFW-02-001
Agitation: Causes and differential diagnosis
Marina Garriga, Spain
TFW-02-002
Agitation in schizophrenia
Dieter Naber, Germany
TFW-02-003
Agitation in Bipolar Disorder (BP)
Lakshmi Yatham, Canada
TFW-02-004
WFSBP Consensus on agitation in psychiatry
Eduard Vieta, Spain
aa
Wednesday, 21 June 2017
T6: BIPOLAR DISORDERS: BASIC/CLINICAL
TFW-03
15:00–16:30
WFSBP Treatment Guideline Session: Do bipolar mixed
states merit a treatment guideline on its own?
Chair:
Siegfried Kasper, Austria
Co-Chair: Heinz Grunze, United Kingdom
TFW-03-001
Clinical manifestations of bipolar mixed states-epidemi-
ological and clinical research
Jean-Michel Azorin, France
TFW-03-002
The changing concept of mixed states over time: DSM5
broadening and downgrading at the same time
Eduard Vieta, Spain
MON TUE WED